Perioperative Analgesia by ESP Catheter on Paediatric Recipient for Liver Transplantation
NCT ID: NCT04838314
Last Updated: 2023-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
12 participants
INTERVENTIONAL
2021-06-01
2023-08-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Erector spinae plane block (ESPB) is an interfascial plane block whereby Local anesthestic (LA) is injected beneath the iliocostalis, longissimus, and spinalis muscles to achieve multi metameric analgesia for pediatric thoracic, cardiac, or abdominal surgery.
I Investigators' hypothesis is with efficient peri operative regional analgesia will reduce the opioids consumption, allow a very early extubation after such long surgeries and improve the quality of recovery by reducing the side effects of opioids as sedation. nausea vomiting delay of first intake.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perioperative Analgesia With Erector Spinae Plane Block in Liver Transplant Recipients
NCT06857331
Erector Spinae Plane Block for Paediatric Upper Abdominal Surgery
NCT04518215
Erector Spinae Plane Block in Liver Transplantation Donors
NCT05406388
Erector Spinae Plane Block in Pediatric Hip Surgery
NCT04354571
Continuous Thoracic Epidural Versus Erector Spinae Plane Block for Postoperative Analgesia in Donar Hepatectomies.
NCT04151511
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Compare quality of analgesia and quality of recovery between bilateral ESP bilateral catheters versus Opioid analgesia in paediatric patients for liver transplantation reduce the peri operative opioid consumption
2. Methodology:
* Selection criteria:
* Age \> 1 to 15 years old
* Have a clinical indication for Liver transplantation ( list for surgeries listed in full proposal)
* Agree to participate in the trial ( Parents or guardians)
* Exclusion criteria:
* Refusal participation.
* Allergy to LA
* Intubated ventilated pre-operation
* Severe coagulation disorder
* Coma
* Prediction of large volume liver implanted
* After surgery performed
* Large volume implanted with a need of post operative controlled ventilation
* Organ failure
* Unstable patient
* Study design: Prospective Randomized Controlled Trial.
Patients who agree to join the study will be randomized into 2 groups:
Group 1 (Control group): standard of care in Liver Transplantation for paediatric recipients: Intra-operative analgesia by Opioid sufentanil and post operative analgesia by patient controled analgesia assisted by nurse opioid morphine based on the protocol established by Prof Lee Vinmec transplantation surgical committee Group 2 (treatment group): Standard peri-operative analgesia for paediatric recipients in institution since we use regional anaesthesia as first line treatment for peri-operative analgesia Bilateral ESP catheters with continuous regional analgesia by infusion of local anesthestic (Ropivacaine) based on the guidelines by paediatric society of anesthesiologists and based on our recent article published in regional anaesthesia and pain medicine
Sample size: We expected to reduce the peri operative opioid consumption by 85% for liver receipt The sample size of 10 patients per group is required to detect such changes assuming a confidence interval of 95% with a power of 90% and alpha = 0.05. Considering 20% of drop-out, the total sample size is 40 patients (20 patients each group)
3. Project outcomes:
The Primary outcome correlation between
* Pain quality evaluated by
* Opioids consumption The secondary outcomes
* Time to extubate
* Time to discharge from Intensive care Unit (ICU) we will create criteria to determinate when patient will discharge from ICU to go to high dependency In most of advanced hospital they don't keep a long time patient in ICU and send the patient to high dependency unit in surgery As in Institution we don't have we will keep the patient in ICU
* Time to discharge from hospital
* Time to first intake
* Any complication related to one type of analgesia
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard of cares
Peri operative analgesia by opioids
No interventions assigned to this group
regional analgesia
Peri operative analgesia by continuous bilateral ESP catheters
regional analgesia
Peri operative regional analgesia by bilateral ESP catheter for 72h
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
regional analgesia
Peri operative regional analgesia by bilateral ESP catheter for 72h
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Allergy to LA
* Intubated ventilated pre-operation
* Severe coagulation disorder
* Coma
* Prediction of large volume liver implanted
* After surgery performed Large volume implanted with a need of post operative controlled ventilation
* After surgery performed Organ failure
* After surgery performed Unstable patient
12 Months
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vinmec Healthcare System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
philippe Macaire, MD
Role: PRINCIPAL_INVESTIGATOR
VinMEC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VinMec International hospital
Hanoi, , Vietnam
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VINMEC-LT-REC-PAED
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.